1254058-26-8

Basic information

• Product Name: tert-butyl (4-amino-1-methylcyclohexyl)carbamate
• Synonyms: tert-butyl (4-amino-1-methylcyclohexyl)carbamate
• CAS NO: 1254058-26-8
• Molecular Weight: 228.335
• Mol File: 1254058-26-8.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: tert-butyl (4-amino-1-methylcyclohexyl)carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl (4-amino-1-methylcyclohexyl)carbamate(1254058-26-8)
• EPA Substance Registry System: tert-butyl (4-amino-1-methylcyclohexyl)carbamate(1254058-26-8)

Safety Data

• Hazardous Substances Data: 1254058-26-8(Hazardous Substances Data)

Usage

General Description

Tert-butyl (4-amino-1-methylcyclohexyl)carbamate is a chemical compound used as a pharmaceutical intermediate or active ingredient in various medications. It is a carbamate derivative with a tert-butyl group attached to a cyclohexyl amine. tert-butyl (4-amino-1-methylcyclohexyl)carbamate is commonly used in the synthesis of urea-based drugs and pesticides due to its ability to inhibit enzyme activity. Tert-butyl (4-amino-1-methylcyclohexyl)carbamate is known for its strong biological activity and has potential applications in the fields of medicine and agriculture. However, it should be handled with caution as it may pose health risks if not used properly.

Upstream product

• 412293-43-7 tert-butyl N-(1-methyl-4-oxo-cyclohexyl)carbamate 

Relevant articles and documents

PURINONE COMPOUNDS AND THEIR USE IN TREATING CANCER

The specification generally relates to compounds of Formula (I): (I) and pharmaceutically acceptable salts thereof, where R1, A1, A2 and A3 have any of the meanings defined herein. The specification also relates to the use of such compounds and salts thereof to treat or prevent DNA-PK mediated disease, including cancer. The specification further relates to pharmaceutical compositions comprising such compounds and salts; kits comprising such compounds and salts; methods of manufacture of such compounds and salts; intermediates useful in the manufacture of such compounds and salts; and to methods of treating DNA-PK mediated disease, including cancer, using such compounds and salts.

PYRAZOLE PYRIMIDINE DERIVATIVE AND USES THEREOF

The present invention provides pyrazole pyrimidine derivatives which inhibit Casein kinase I (CKI) and/or lnterleukin-1 receptor-associated kinase 1 (IRAKI) and methods of their manufacture, compositions comprising them and uses thereof in methods of treating malignant disease and disorders and methods for treating inflammatory diseases and disorders.